Esther Tamayo Revuelta-rekin lankidetzan egindako argitalpenak (9)

2014

  1. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration

    Journal of Controlled Release, Vol. 173, Núm. 1, pp. 132-139

2013

  1. A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system

    International Journal of Pharmaceutics, Vol. 440, Núm. 1, pp. 19-26

  2. Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART A, pp. 665-672

  3. Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia

    International Journal of Pharmaceutics, Vol. 454, Núm. 2, pp. 784-790

  4. PEGylated-PLGA microparticles containing VEGF for long term drug delivery

    International Journal of Pharmaceutics, Vol. 440, Núm. 1, pp. 13-18

2012

  1. Angiogenic therapy for cardiac repair based on protein delivery systems

    Heart Failure Reviews, Vol. 17, Núm. 3, pp. 449-473

  2. Drug Delivery in Tissue Engineering: General Concepts

    Nanostructured Biomaterials for Overcoming Biological Barriers (The Royal Society of Chemistry), pp. 501-526

  3. Vascular endothelial growth factor-delivery systems for cardiac repair: An overview

    Theranostics, Vol. 2, Núm. 6, pp. 541-552

2010

  1. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model

    Journal of Controlled Release, Vol. 147, Núm. 1, pp. 30-37